TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2709252

Group type: EXPERIMENTAL
Intervention: Fortified human milk (breast-milk fortifier mixed with mother's milk)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Human milk (breast-milk only)
Number of subjects: 59
Study: 1268451

Group type: EXPERIMENTAL
Intervention: Negative reinforcement ('bad' and electric shock) with both female and male experimenters
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Positive reinforcement ('good') with male experimenter
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Positive reinforcement ('good') with female experimenter
Number of subjects: 80
Study: 31312890

Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Performance of the resection by a trainee
Number of subjects: 501
Study: 28774885

Group type: EXPERIMENTAL
Intervention: MNP with 5 mg iron (Fe group)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: MNP with 7.5 g GOS and 5 mg iron (FeGOS group)
Number of subjects: 155

Group type: COMPARATOR
Intervention: MNP without iron (control)
Number of subjects: 155
Study: 26387721

Group type: EXPERIMENTAL
Intervention: Cox Maze-IV procedure using the AtriCure Synergy bipolar radiofrequency ablation system
Number of subjects: 55
Study: 23816760

Group type: EXPERIMENTAL
Intervention: S-1 plus carboplatin; S-1 at 80 mg/m²/day for 2 weeks, followed by 2 weeks of no treatment; Carboplatin at AUC 6 on day 8, repeated for 4-6 cycles of 28 days
Number of subjects: 17
Study: 21639811

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic-valve replacement
Number of subjects: 699

Group type: COMPARATOR
Intervention: Surgical aortic-valve replacement
Number of subjects: 699
Study: 19878831

Group type: EXPERIMENTAL
Intervention: Gatifloxacin 0.3% eyedrops
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Levofloxacin 0.5% eyedrops
Number of subjects: 152
Study: 16924046

Group type: EXPERIMENTAL
Intervention: 5% fluorouracil cream applied twice daily for 3 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 30% trichloroacetic acid peel
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser resurfacing
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (5 of 7 eligible patients who declined study-related treatment)
Number of subjects: 34
Study: 15276393

Group type: EXPERIMENTAL
Intervention: Peer-led sex education
Number of subjects: 8000

Group type: COMPARATOR
Intervention: Teacher-led sex education
Number of subjects: 8000
Study: 11167663

Group type: EXPERIMENTAL
Intervention: Moxonidine (0.1, 0.2, 0.3 mg twice daily)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 9042124

Group type: EXPERIMENTAL
Intervention: 5 ppm nitric oxide
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 20 ppm nitric oxide
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control period (15 minutes before and after treatment)
Number of subjects: 23
Study: 7488463

Group type: EXPERIMENTAL
Intervention: High risk intervention group (n = 612)
Number of subjects: 3313

Group type: COMPARATOR
Intervention: Randomised control group (n = 610)
Number of subjects: 3313

Group type: EXPERIMENTAL
Intervention: Non-participant low risk group (n = 593)
Number of subjects: 3313

Group type: EXPERIMENTAL
Intervention: Refused group (n = 867)
Number of subjects: 3313

Group type: EXPERIMENTAL
Intervention: Excluded group (n = 563)
Number of subjects: 3313

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 612)
Number of subjects: 3313

Group type: EXPERIMENTAL
Intervention: Intervention and control groups combined
Number of subjects: 3313
Study: 2145654

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg almitrine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 100 mg medroxyprogesterone
Number of subjects: 6

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 6
Study: 6996483

Group type: EXPERIMENTAL
Intervention: Dilatation and evacuation (D‐E)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intra-amniotic instillation of prostaglandin F2 alpha (PGF2 alpha)
Number of subjects: 100
Study: 31843676

Group type: EXPERIMENTAL
Intervention: Simultaneous resection
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Staged resection
Number of subjects: 1168
Study: 29686382

Group type: EXPERIMENTAL
Intervention: Ten Top Tips (TTT)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Do Something Different (DSD)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 75
Study: 27379830

Group type: COMPARATOR
Intervention: No breakfast
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-protein/low-carbohydrate breakfast
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low-protein breakfast
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-carbohydrate/low-protein breakfast
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-protein breakfast
Number of subjects: 33
Study: 23122840

Group type: EXPERIMENTAL
Intervention: 1 IU of oxytocin followed by an infusion of 2.5 UI×h(‐1)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 20 IU oxytocin at a rate of 700 mUI×min(‐1) followed later by 10 UI×h(‐1)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 100μg bolus dose of carbetocin
Number of subjects: 104
Study: 21147188

Group type: EXPERIMENTAL
Intervention: 15IPM
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 30IPM
Number of subjects: 20

Group type: COMPARATOR
Intervention: noIPM
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 15IPM vs 30IPM
Number of subjects: 20
Study: 19054496

Group type: EXPERIMENTAL
Intervention: 4 mg intravitreal triamcinolone acetonide (TA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 40 mg orbital floor triamcinolone acetonide (TA)
Number of subjects: 40
Study: 17601892

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 299

Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 299
Study: 15336749

Group type: EXPERIMENTAL
Intervention: High elevation at home
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple sling
Number of subjects: 0
Study: 11504984

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 211

Group type: COMPARATOR
Intervention: Protease Inhibitor (PI)
Number of subjects: 211
Study: 9006811

Group type: COMPARATOR
Intervention: Extended-release gemfibrozil (1200 mg/day) for 3 months
Number of subjects: 884

Group type: EXPERIMENTAL
Intervention: Regular gemfibrozil (1200 mg/day) for 6 months
Number of subjects: 884
Study: 1338215

Group type: EXPERIMENTAL
Intervention: 1.75% THC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3.55% THC
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6376209

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 50 mg plus triamterene 50 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Chlorthalidone 50 mg
Number of subjects: 88
Study: 31085948

Group type: EXPERIMENTAL
Intervention: Intensive treatment (target SBP < 140 mmHg)
Number of subjects: 3233

Group type: COMPARATOR
Intervention: Guideline-recommended treatment (SBP < 180 mmHg)
Number of subjects: 3233
Study: 28520924

Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 10372

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 10372

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 10372
Study: 27056899

Group type: EXPERIMENTAL
Intervention: EC/T (epirubicin, cyclophosphamide and paclitaxel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CEF (cyclophosphamide, epirubicin and flurouracil)
Number of subjects: 0
Study: 24643119

Group type: EXPERIMENTAL
Intervention: 18-Hz stimulation of the left dorsolateral prefrontal cortex (PFC)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 5-Hz stimulation of the primary motor cortex (MC)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 13
Study: 22295813

Group type: EXPERIMENTAL
Intervention: Distant acupuncture and nearby tuina therapy (30 treatments)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Calcium Carbonate D, Tablet (orally for 12 weeks)
Number of subjects: 64
Study: 20814848

Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg od
Number of subjects: 76

Group type: COMPARATOR
Intervention: Losartan 100 mg od
Number of subjects: 76
Study: 17491103

Group type: EXPERIMENTAL
Intervention: AVJAP
Number of subjects: 48

Group type: COMPARATOR
Intervention: MED
Number of subjects: 48
Study: 15709830

Group type: EXPERIMENTAL
Intervention: Adolescent Coping With Depression (CWD‐A) course
Number of subjects: 93

Group type: COMPARATOR
Intervention: Life skills control condition
Number of subjects: 93
Study: 11896100

Group type: EXPERIMENTAL
Intervention: EU/5-FU (11.5 mg/m²/1.15 mg/m² twice daily for 28 days every 35 days)
Number of subjects: 981

Group type: COMPARATOR
Intervention: 5-FU/LV (425 mg/m²/20 mg/m² once daily for 5 days every 28 days)
Number of subjects: 981

Group type: EXPERIMENTAL
Intervention: EU/5-FU
Number of subjects: 981

Group type: COMPARATOR
Intervention: 5-FU/LV
Number of subjects: 981
Study: 10661600

Group type: EXPERIMENTAL
Intervention: Mianserin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Fenfluramine challenge test
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Fenfluramine challenge test with length of illness history
Number of subjects: 47
Study: 8677155

Group type: COMPARATOR
Intervention: Antioxidant enzymes (glutathione reductase and glutathione S‐transferase)
Number of subjects: 0
Study: 2008971

Group type: EXPERIMENTAL
Intervention: Centrifugation method (Compur M 1100)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Centrifugation method (Stat‐Crit)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reference method (Coulter counter Model S + 2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dilution with dextran 40
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dilution with fluid modified gelatin (Plasmion)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Resistivity technique for samples diluted with gelatin
Number of subjects: 10
Study: 7008799

Group type: EXPERIMENTAL
Intervention: Prednisone plus azathioprine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 2
Study: 30753252

Group type: EXPERIMENTAL
Intervention: Low-protein diet
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Very-low-protein diet
Number of subjects: 674
Study: 27612996

Group type: EXPERIMENTAL
Intervention: HDL cholesterol efflux capacity
Number of subjects: 1147
Study: 27544544

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (2000 IU daily from 26 to 28 weeks of gestation until childbirth)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 24756487

Group type: EXPERIMENTAL
Intervention: Warmed, humidified carbon dioxide
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard carbon dioxide
Number of subjects: 148
Study: 21639722

Group type: EXPERIMENTAL
Intervention: Unsupervised aerobic training for 50 minutes four times per week during 6 months
Number of subjects: 176
Study: 19731176

Group type: EXPERIMENTAL
Intervention: Interval training and diet education (INT group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Continuous aerobic exercise and diet education (CON group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diet education only (DIET group)
Number of subjects: 24
Study: 17499406

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Challenge dose of quadrivalent HPV vaccine
Number of subjects: 552

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 552
Study: 14983409

Group type: EXPERIMENTAL
Intervention: 100 mg androstenedione
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 300 mg androstenedione
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 11601954

Group type: EXPERIMENTAL
Intervention: Pharmacologic treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonpharmacologic treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Regional and subspecialty variations
Number of subjects: 0
Study: 9972083

Group type: EXPERIMENTAL
Intervention: Nasal catheter
Number of subjects: 99

Group type: COMPARATOR
Intervention: Nasal prongs
Number of subjects: 99
Study: 7846253

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: None (other DSM-III-R criteria)
Number of subjects: 80
Study: 3370523

Group type: EXPERIMENTAL
Intervention: Moisture-vapour-permeable film (MVPF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silver sulphadiazine
Number of subjects: 0
Study: 28732813

Group type: EXPERIMENTAL
Intervention: Curcuma longa
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Angelica sinensis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Panax ginseng
Number of subjects: 25

Group type: COMPARATOR
Intervention: Aspirin with Curcuma longa
Number of subjects: 25

Group type: COMPARATOR
Intervention: Aspirin with Angelica sinensis
Number of subjects: 25

Group type: COMPARATOR
Intervention: Aspirin with Panax ginseng
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Curcuma longa, Angelica sinensis, Panax ginseng
Number of subjects: 25
Study: 25109412

Group type: EXPERIMENTAL
Intervention: Immediate-release guanfacine (4 mg)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Immediate-release guanfacine (8 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg)
Number of subjects: 83
Study: 23294775

Group type: EXPERIMENTAL
Intervention: Dulaglutide (dula, LY2189265)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed-dose design
Number of subjects: 0
Study: 21410033

Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides/short-chain triglycerides (MCT/LCT) physical mixture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Four-component intravenous lipid emulsion (LCT, MCT, Olive-oil and Fish-oil)
Number of subjects: 0
Study: 17668982

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 15830009

Group type: EXPERIMENTAL
Intervention: Interferon alpha (IFN)
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 856

Group type: COMPARATOR
Intervention: Control group (Hydroxyurea alone)
Number of subjects: 856

Group type: EXPERIMENTAL
Intervention: Busulfan
Number of subjects: 856
Study: 12102380

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10459328

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 8546294

Group type: EXPERIMENTAL
Intervention: Droperidol (1.25 mg) with morphine (1 mg.ml‐1)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg) with morphine (1 mg.ml‐1)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Morphine (1 mg.ml‐1) alone
Number of subjects: 145
Study: 2201992

Group type: EXPERIMENTAL
Intervention: oral acyclovir
Number of subjects: 21

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21
Study: 360779

Group type: EXPERIMENTAL
Intervention: Amitriptyline-N-oxide
Number of subjects: 43

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 43
Study: 31250889

Group type: EXPERIMENTAL
Intervention: 6 g BCAA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 6 g BCKA
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 30 g MILK
Number of subjects: 45
Study: 29879719

Group type: EXPERIMENTAL
Intervention: Nimodipine plus Yufeng Ningxin tablets
Number of subjects: 242

Group type: COMPARATOR
Intervention: Flunarizine
Number of subjects: 242
Study: 27222260

Group type: EXPERIMENTAL
Intervention: Standardised formal neonatal resuscitation training (SFNRT)
Number of subjects: 66162

Group type: EXPERIMENTAL
Intervention: Teamwork training with simulation
Number of subjects: 66162
Study: 25195137

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (without NIV)
Number of subjects: 13
Study: 22429354

Group type: EXPERIMENTAL
Intervention: Ropivacaine (thoracic epidural block)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Remifentanil (intravenous)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clonidine (intravenous)
Number of subjects: 60

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 60
Study: 20124231

Group type: EXPERIMENTAL
Intervention: IVIG, 0.5 g/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 12
Study: 18853648

Group type: EXPERIMENTAL
Intervention: Motor rehabilitation after radical mastectomy
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Patients with large mass (>69.2 kg), WHR (>0.94), Quetelet's (>448.7), Rohrer's (>1.76), and Pignet-Verwaeck's (107.7)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Slim body build and low index values
Number of subjects: 86
Study: 16221778

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 2781

Group type: COMPARATOR
Intervention: Hepatitis A vaccine (control)
Number of subjects: 2781
Study: 12135030

Group type: EXPERIMENTAL
Intervention: 9 mg budesonide CIR once daily
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 4.5 mg budesonide CIR b.i.d.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 9989566

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 29
Study: 8578018

Group type: EXPERIMENTAL
Intervention: Roxithromycin (low dose for a long period of time)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 0
Study: 2162296

Group type: EXPERIMENTAL
Intervention: Glucose as the sole non-protein energy source
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glucose-lipid mixture
Number of subjects: 10
Study: 7468062

Group type: EXPERIMENTAL
Intervention: Heparin (5000 units every 12 hours for 10 days)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Heparin + Dihydroergotamine (0.5 mg at the same intervals as heparin)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Saline (acting as control)
Number of subjects: 210
Study: 31779689

Group type: EXPERIMENTAL
Intervention: GP or nurse-led brief advice about e‐cigarettes, an e‐cigarette starter pack, practical support booklet, and telephone support from experienced vapers and online video tutorials.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study: 29335051

Group type: EXPERIMENTAL
Intervention: 3-month recall (3-MR) and 6-month recall (6-MR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 6-month recall (6-MR)
Number of subjects: 0
Study: 25927298

Group type: EXPERIMENTAL
Intervention: Intervention targeting to narrow SES differences in energy balance-related behaviors (EBRBs) in preschool settings.
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Accelerometer usage for seven days to measure physical activity (PA).
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Questionnaires completed by parents and preschool personnel regarding EBRBs, social and physical environments, and SES factors.
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Biological measurements including hair and saliva samples.
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Quality of preschool environment observed.
Number of subjects: 800
Study: 23337477

Group type: EXPERIMENTAL
Intervention: lanreotide Autogel 60 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: lanreotide Autogel 90 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: lanreotide Autogel 90 mg (adjusted according to clinical responses)
Number of subjects: 32
Study: 21890085

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 199

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg/day
Number of subjects: 199
Study: 19052047

Group type: EXPERIMENTAL
Intervention: Breathing training
Number of subjects: 183

Group type: COMPARATOR
Intervention: Asthma education
Number of subjects: 183
Study: 18625052

Group type: EXPERIMENTAL
Intervention: Intervention 1
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Intervention 2
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Intervention 3
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Intervention 4
Number of subjects: 389
Study: 15762970

Group type: EXPERIMENTAL
Intervention: Physical training (n=8)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (n=11)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 19
Study: 12038945

Group type: EXPERIMENTAL
Intervention: 2-mg nicotine lozenge
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: 4-mg nicotine lozenge
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Active lozenge
Number of subjects: 1818

Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 1818
Study: 10203653

Group type: EXPERIMENTAL
Intervention: McCall-type culdeplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vaginal Moschcowitz-type procedure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Peritoneal closure only
Number of subjects: 100
Study: 7702188

Group type: EXPERIMENTAL
Intervention: Diltiazem (DIL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nitroglycerin (NTG)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diltiazem/Nitroglycerin (DIL/NTG)
Number of subjects: 90
Study: 2665802

Group type: EXPERIMENTAL
Intervention: Active ultrasound
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Active pulsed electromagnetic energy
Number of subjects: 414

Group type: COMPARATOR
Intervention: Placebo therapies
Number of subjects: 414
Study: 339214

Group type: EXPERIMENTAL
Intervention: Once daily atenolol (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Twice daily atenolol (100 mg or 50 mg)
Number of subjects: 12
Study: 29806553

Group type: EXPERIMENTAL
Intervention: Glucose solution (50 g/300 ml of water)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Plain water
Number of subjects: 25
Study: 31623656

Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation combined with active tDCS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional rehabilitation combined with sham tDCS
Number of subjects: 80